EGFR and lung cancer: A large amount of evidence and studies show that mutations of the Kirsten rat sarcoma viral oncogene (KRAS), epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and P53 play an important role in the occurrence of lung cancer (6–8).